Approval · Notice of Compliance 19079 · 2017
ZEVTERA: Notice of Compliance 19079
Issued February 7, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19079
- Date
- February 7, 2017
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To increase the drug product's shelf life specifications for two individual and total degredation products
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZEVTERA | Not yet assigned | — |
Medicinal ingredients
- CEFTOBIPROLE MEDOCARIL 500 MG per VIAL